Interactive newsletters capture the latest updates and review clinical pearls in the diagnosis and treatment of patients with IPF.  


The August 2016 issue of PILOT Connect features podcasts on emerging IPF treatments and on inhaled NAC for IPF, a publication review on outcomes after treating GERD, and an interactive radiology webinar highlighting the key features of HRCTs that help in the diagnosis of ILD.

Marilyn K. Glassberg, MD, Jonathan Goldin, MD, PhD, Amy L. Olson, MD, MSPH, Maria Padilla, MD, Luca Richeldi, MD, PhD and Timothy Whelan, MD


padilla 168x168

Our June 2016 issue features video discussions, publication reviews, and podcasts. It starts with Drs. Nathan and Flaherty discussing when to start, and when to continue, IPF Treatments. Dr. Brown reviews two new publications on pooled analyses from pivotal pirfenidone and nintedanib clinical trials. Finally, Drs. Padilla and Whelan discuss efficacy, safety, and current evidence on combining nintedanib and pirfenidone.

Steven Nathan, MD, Kevin Flaherty, MD, MS, A. Whitney W. Brown, MD, Maria Padilla, MD, and Timothy P. M. Whelan, MD


Timothy Whelan, MD

Two new publications are reviewed in this issue. Dr. Whelan reviews preliminary results of a new approach to treating acute exacerbations of IPF, as well as surprising survival results after lung transplantation. Short videos feature Dr. Nathan (Exciting Results from 2015 CHEST and ERS meetings), Dr. Richeldi (New Trends in IPF), Dr. Kaminski (Biomarkers for IPF), and Dr. Tager (Discovering New Drugs for IPF). Drs. Collard and Nathan discuss managing patients with IPF. Finally, a caregiver reflects on a PILOT regional symposium.

Harold Collard, MD, Naftali Kaminski, MD, Steven Nathan, MD, Luca Richeldi, MD, Andrew Tager, MD, Timothy Whelan, MD


nathan clr

Four new publications are reviewed in this issue. They explore innovative approaches to treating IPF and its acute exacerbations, as well as a subgroup analysis of the PANTHER study. Drs. Lederer and Raghu discuss the recent IPF Treatment Guidelines and review the 2015 ATS Conference. Finally, Dr. Lamberti introduces us to the National Association for Medical Direction of Respiratory Care (NAMDRC) and reviews the annual meeting.

Steven Nathan, MD; David Lederer, MD, MS; Ganesh Raghu, MD, FACP, FCCP; and James P. Lamberti, MD



This issue features a pro/con debate on the new IPF treatments, a review of a challenging treatment case, and further IPF treatment Q&A.

Marilyn Glassberg, MD; Charlie Strange, MD, FCCP and Imre Noth, MD



This issue features IPF Treatment Q&A, a review of a recently published article, Diagnostic Dilemmas (available for credit), and reviews recently released materials and upcoming events.

Kevin Flaherty, MD, MS; Marilyn Glassberg, MD; and Imre Noth, MD

nathan clr

This issue highlights recent news and publications outlining developments in IPF, provides a presentation of a systematic diagnosis approach for challenging cases, and reviews recently released materials and upcoming events. NOTE: iOS users, for best viewing use iBooks.

Steven D. Nathan, MD (Chair) and Imre Noth, MD

Paul Noble, MD

This issue highlights discussions on the latest published clinical trials (ASCEND, INPULSIS, and PANTHER) and includes a forum to share your opinions and learn how they compare with your colleagues. NOTE: iOS users, for best viewing use iBooks.

Paul Noble, MD (Chair); Harold R. Collard, MD; Vincent Cottin, MD, PhD; Sonye K. Danoff, MD, PhD; David J. Lederer, MD, MS; Luca Richeldi, MD, PhD